Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumoursA Awada, F A L M Eskens, M Piccart, et al.British Journal of Cancer|March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studyE Van Cutsem, L Dirix, J-L Van Laethem, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use programS Brienza, M A Bensmaïne, P Soulié, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumorsE Van Den Neste, D de Valeriola, J Kerger, et al.European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trialC Grimaldi, H Bleiberg, F Gay, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedulesA Awada, S Giacchetti, B Gerard, et al.British Journal of Cancer|February 23, 1999
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigenJ N Primrose, H Bleiberg, F Daniel, et al.Pageof 13